{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:38:06Z","timestamp":1788817086968,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.lfs.2026.124250","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:08:00Z","timestamp":1769818080000},"page":"124250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ezrin (EZR) promotes breast cancer progression and drug resistance: Molecular mechanisms involving STAT3 activation"],"prefix":"10.1016","volume":"390","author":[{"given":"Hongshan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124250_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1037531","article-title":"ESR1 fusions and therapeutic resistance in metastatic breast cancer","volume":"12","author":"Nagy","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2026.124250_bb0010","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4103\/jcrt.jcrt_608_23","article-title":"Tamoxifen induces ferroptosis in MCF-7 organoid","volume":"19","author":"Ye","year":"2023","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.lfs.2026.124250_bb0015","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1556\/650.2023.32796","article-title":"Daganatos betegek glykaemi\u00e1s \u00e9s t\u00e1pl\u00e1lts\u00e1gi \u00e1llapot\u00e1nak vizsg\u00e1lata","volume":"164","author":"B\u00e1nhegyi","year":"2023","journal-title":"OH"},{"key":"10.1016\/j.lfs.2026.124250_bb0020","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/CM9.0000000000003278","article-title":"Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022","volume":"137","author":"Sun","year":"2024","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.lfs.2026.124250_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","article-title":"The lingering mysteries of metastatic recurrence in breast cancer","volume":"124","author":"Riggio","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2026.124250_bb0030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jcmm.12054","article-title":"Mechanotransduction at focal adhesions: integrating cytoskeletal mechanics in migrating cells","volume":"17","author":"Kuo","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2026.124250_bb0035","article-title":"Targeting mechanotransduction in osteosarcoma: a comparative oncology perspective","volume":"21","author":"Luu","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.lfs.2026.124250_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-014-0438-2","article-title":"A novel role for ezrin in breast cancer angio\/lymphangiogenesis","volume":"16","author":"Ghaffari","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.lfs.2026.124250_bb0045","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2023.05.022","article-title":"Inherited human ezrin deficiency impairs adaptive immunity","volume":"152","author":"Garc\u00eda-Sol\u00eds","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2026.124250_bb0050","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jclinpath-2020-207068","article-title":"Epithelial\u2013mesenchymal transition and cancer stem cell interactions in breast phyllodes tumours: immunohistochemical evaluation of EZH2, EZR, HMGA2, CD24 and CD44 in correlation with outcome analysis","volume":"75","author":"Ahmed","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lfs.2026.124250_bb0055","article-title":"Pathophysiological roles of actin-binding scaffold protein, ezrin","volume":"23","author":"Kawaguchi","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.lfs.2026.124250_bb0060","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.3390\/cells12121620","article-title":"Ez-metastasizing: the crucial roles of ezrin in metastasis","volume":"12","author":"Buenaventura","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2026.124250_bb0065","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/1878-0261.13054","article-title":"Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets","volume":"16","author":"Dr\u00e4ger","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.lfs.2026.124250_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-021-00757-z","article-title":"The cell adhesion molecule TMIGD1 binds to moesin and regulates tubulin acetylation and cell migration","volume":"28","author":"Rahimi","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2026.124250_bb0075","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/1878-0261.13442","article-title":"Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways","volume":"17","author":"Chang","year":"2023","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.lfs.2026.124250_bb0080","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1002\/cam4.1682","article-title":"MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2","volume":"7","author":"Liu","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.lfs.2026.124250_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-020-00510-w","article-title":"METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner","volume":"53","author":"Pan","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2026.124250_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03565-3","article-title":"CircRNA circ_0124554 blocked the ubiquitination of AKT promoting the skip lymphovascular invasion on hepatic metastasis in colorectal cancer","volume":"12","author":"Tang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2026.124250_bb0095","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1200\/JCO.1996.14.6.1877","article-title":"Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer","volume":"14","author":"Seidman","year":"1996","journal-title":"JCO"},{"key":"10.1016\/j.lfs.2026.124250_bb0100","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1200\/JCO.1995.13.10.2575","article-title":"Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer","volume":"13","author":"Seidman","year":"1995","journal-title":"JCO"},{"key":"10.1016\/j.lfs.2026.124250_bb0105","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1038\/cddis.2013.167","article-title":"Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation","volume":"4","author":"Notte","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2026.124250_bb0110","article-title":"Breast cancer resistance to cyclin-dependent kinases 4\/6 inhibitors: intricacy of the molecular mechanisms","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2026.124250_bb0115","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.3390\/ijms22115850","article-title":"Current understanding of neurofibromatosis type 1, 2, and Schwannomatosis","volume":"22","author":"Tamura","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.lfs.2026.124250_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.807600","article-title":"Platelet CLEC2-podoplanin axis as a promising target for oral cancer treatment","volume":"12","author":"Hwang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124250_bb0125","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/cells12091257","article-title":"Deletion of Cd44 inhibits metastasis formation of liver cancer in Nf2-mutant mice","volume":"12","author":"Gerardo-Ram\u00edrez","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2026.124250_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.32604\/or.2022.026616","article-title":"Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer","volume":"30","author":"Xiao","year":"2022","journal-title":"Oncol. Res."},{"key":"10.1016\/j.lfs.2026.124250_bb0135","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/cancers11111646","article-title":"STAT3: an emerging therapeutic target for hepatocellular carcinoma","volume":"11","author":"Lee","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2026.124250_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00072","article-title":"Comparative STAT3-regulated gene expression profile in renal cell carcinoma subtypes","volume":"9","author":"Robinson","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2026.124250_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101901","article-title":"Insights into molecular mechanisms of chemotherapy resistance in cancer","volume":"42","author":"Kar","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.lfs.2026.124250_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109631","article-title":"HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression","volume":"72","author":"Lei","year":"2020","journal-title":"Cell. Signal."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:17:21Z","timestamp":1772241441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"alternative-id":["S0024320526000585"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124250","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ezrin (EZR) promotes breast cancer progression and drug resistance: Molecular mechanisms involving STAT3 activation","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124250"}}